Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial

201158 citationsJournal Article

Authors

P. Raskin · The University of Texas Southwestern Medical Center

Simon Heller · Sheffield Teaching Hospitals NHS Foundation Trust

Miikka‐Juhani Honka · University Hospital Ostrava

Po‐Chun Chang · MannKind Corporation (United States)

Anders Boss · MannKind Corporation (United States)

Peter Richardson · MannKind Corporation (United States)

Nikhil Amin

Abstract

Observed changes in lung function with TI were small, occurred early after therapy initiation, remained non-progressive over 2 years and were unlikely to be clinically meaningful.

Topics & Keywords

Chronic Obstructive Pulmonary Disease (COPD) Research Inhalation and Respiratory Drug Delivery Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

UN Sustainable Development Goals

Clean water and sanitation

Publication Details

Published in: Diabetes Obesity and Metabolism

Volume 14, Issue 2, pp. 163-173

DOI: 10.1111/j.1463-1326.2011.01500.x

Field-Weighted Citation Impact: 3.89